The results of clone formation and transwell assays showed that the addition of the CXCL12/CXCR4 signaling pathway by the inhibitor, AMD3100, reverses the increase in the proliferation and migration of gastric cancer cells that was caused by KDM6B ectopic expression (Fig. 6C, D). Here, KDM6B is linked to gastric cancer.